Skip to main content

People in the News: Richard Tompane, Thomas Musci

Premium

Genomic Health has appointed Richard Tompane as president of its new subsidiary InVitae, which will focus on developing next-generation-based sequencing diagnostics for genetic diseases. Tompane was previously president and CEO of Gemfire and has also served as an independent consultant.


Ariosa Diagnostics has appointed Thomas Musci to be vice president of clinical development and medical affairs. Musci was chair of the Genetics Committee for the American Congress of Obstetricians and Gynecologists. He is a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics and holds an appointment as associate clinical professor with the Department of Obstetrics and Gynecology at the University of California, San Francisco. He was also formerly the director of clinical affairs for Predictive Health and Novartis Diagnostics.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.